Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations. - Test2 - elhamkhani - TriplyDB

Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.

Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.

http://www.wikidata.org/entity/Q30390764

about

Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery.Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology.Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs

P2860

Q35883589-E1BF2095-5991-46F2-BB4F-29FF1EE44FE0 Q50854702-7F15F1C4-0A31-445F-95CF-C15EA88DF98F Q58032213-3165C351-7020-4218-948E-995D54228B75

P2860

Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.

http://www.wikidata.org/entity/Q30390764

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Modulating Drug Release and En ...... Lipid Dispersion Formulations.

@ast

Modulating Drug Release and En ...... Lipid Dispersion Formulations.

@en

type

label

Modulating Drug Release and En ...... Lipid Dispersion Formulations.

@ast

Modulating Drug Release and En ...... Lipid Dispersion Formulations.

@en

prefLabel

Modulating Drug Release and En ...... Lipid Dispersion Formulations.

@ast

Modulating Drug Release and En ...... Lipid Dispersion Formulations.

@en

P1433

Q30390764-76007FDC-5D4C-43F8-9B33-63E75F50DF49

P1476

Q30390764-F5E0F4E8-B300-4219-B351-EEF789128DF7

P2093

Q30390764-0ACA8E68-F251-485E-8868-CA6F15EFDBEA

Q30390764-5164C33C-4895-4722-AE07-834ABB5140F8

Q30390764-68FE60F4-C0BF-443C-85D2-CC8F3FE21A75

Q30390764-D61636BA-A576-4F08-B493-949393C3B46C

Q30390764-DB1FB812-503B-4C99-B981-28760E4DF82A

P2860

Q30390764-01058F34-F624-477B-B0D3-C562DE1B712A

Q30390764-31BBA9C1-47C2-4139-88B2-C175D551C3D3

Q30390764-414B8F30-BE6E-42C6-B5F9-03F5FA25181E

Q30390764-4A22637E-EA47-4A9D-BA99-AF8DDD48BD7E

Q30390764-4AE22622-9B24-43A9-AAF9-A82C1DAC6B99

Q30390764-6C9FD5F6-8ED7-44CF-8177-59A32824E99B

Q30390764-70DCAABE-5F30-4CFE-BBFC-181B9E91BBFC

Q30390764-775B19EF-40A2-4EC1-B822-33C61AB4B192

Q30390764-7B8A167A-ECED-4E4C-B05E-F9D1B14CC651

Q30390764-7E92B6CF-E64D-4459-8822-363B506A117C

P2888

Q30390764-B88AA8F5-E22D-4AC3-881D-37F09D6715B4

P304

Q30390764-2994DAC5-76E5-41CC-9B91-9345ED3E36FA

P31

Q30390764-38D6A236-295F-4A98-8C39-121C8290E916

P356

Q30390764-D3EC36AF-3845-4F81-AF40-679FB74C73C1

P407

Q30390764-CF3A4C1D-5B27-479D-853B-EEEB9CDB4B64

P433

Q30390764-6E5EADE4-C6D4-4AF3-84F6-0BB2BC4C1F31

P478

Q30390764-26BEEEED-C164-434C-A97D-A85A67D49D10

P577

Q30390764-CB8C2536-B7FA-43C2-A28B-95F956610DC5

P6179

Q30390764-2F4E2DA4-26D0-4717-9327-8FDF4261903A

P698

Q30390764-07AF526F-C65F-4E8A-8BCD-7E89423E280E

P932

Q30390764-E007B607-8313-4BC2-AC02-78D19E574922

P356

S12249-015-0299-8

P1433

AAPS PharmSciTech

P1476

Modulating Drug Release and En ...... Lipid Dispersion Formulations.

@en

P2093

Annette Bak

http://www.w3.org/2001/XMLSchema#string

Dennis H Leung

http://www.w3.org/2001/XMLSchema#string

Gino M Salituro

http://www.w3.org/2001/XMLSchema#string

Keun-Joong Lee

http://www.w3.org/2001/XMLSchema#string

Yajun Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic

Improving drug solubility for oral delivery using solid dispersions.

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.

Single bilayer liposomes prepared without sonication.

Solid lipid nanoparticles: production, characterization and applications.

Formulation and characterization of curcuminoids loaded solid lipid nanoparticles.

Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications.

Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.

Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.

P2888

s12249-015-0299-8

P304

1091-1100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12249-015-0299-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006617561

http://www.w3.org/2001/XMLSchema#string

P698

25690735

http://www.w3.org/2001/XMLSchema#string

P932

4674632

http://www.w3.org/2001/XMLSchema#string